Apixaban for Treatment of Embolic Stroke of Undetermined Source "ATTICUS"

Recruiting

Phase 3 Results N/A

Summary of Purpose

Multicentre (national, Germany), randomized (2x2 factorial), open, parallel group, active controlled, efficacy study (phase III)

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 June 2016.

1 Dec 2015 20 Mar 2015 1 Dec 2018 1 Dec 2019 1 Jun 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts